Citrus trees showing natural tolerance to citrus greening disease host bacteria that produce novel antimicrobials that can be used to fight off the disease, our recent study shows. We found the trees at an organic farm in Clermont, Florida.
Infected trees produce fewer fruit. The fruit that does grow is partially green, smaller, shaped irregularly and bitter tasting. It may drop from the trees before ripening. Leaves may show blotchy mottling.
Advertisement
According to the U.S. Department of Agriculture, the 2022-2023 growing season was the least productive since 1936. Smaller crops lead to higher prices on oranges, tangerines, grapefruits, lemons and limes.
In a search for treatments against HLB, we looked to endophytes of survivor citrus trees – in other words, trees that are HLB positive but showed only mild symptoms and continue to bear fruit. By studying 342 endophytes of survivor trees, we discovered five bacterial endophytes capable of producing novel antimicrobials.
Advertisement
The HLB bacteria cannot be grown on laboratory culture media like agar or broth. So, we used live bacterial cells present in the ground tissue samples of infected psyllids to test the antimicrobial compounds in the lab. These studies revealed that the antimicrobial compounds were highly effective at killing the live cells of citrus greening pathogen in this controlled environment. The antimicrobials can be mixed with water and were found to be effective at low concentrations.
What’s still not known
Preliminary results from our ongoing work indicate that multiple antimicrobial compounds are present in the bacterial culture extract. This is a positive sign because the antimicrobial compounds may be found to attack pathogenic bacteria in several different ways. If that’s the case, it will help minimize the development of resistance in the same way a variety of antibiotics are useful to human doctors.
One of our next steps will be to evaluate selected compounds against HLB, using infected citrus roots under laboratory conditions and infected citrus plants under greenhouse conditions, to test whether the plants will absorb these antimicrobial compounds through their leaves or roots. This work will be conducted in collaboration with scientists from Texas A&M University and the University of Florida.
What’s next
Further research will focus on methods to increase the production of purified antimicrobial compound in order for it to be evaluated in the field. To help get the technology to growers faster, we may look for partnerships with interested commercial biopesticide companies to help with product development.
Advertisement
Our work has taken on new urgency due to emerging psyllid-transmitted diseases that infect potato, tomato and carrot crops in the U.S. that are caused by closely related bacterial pathogens.
The Research Brief is a short take on interesting academic work.
This relatively long transit time is a result of the use of traditional chemical rocket fuel. An alternative technology to the chemically propelled rockets the agency develops now is called nuclear thermal propulsion, which uses nuclear fission and could one day power a rocket that makes the trip in just half the time.
Advertisement
Nuclear fission involves harvesting the incredible amount of energy released when an atom is split by a neutron. This reaction is known as a fission reaction. Fission technology is well established in power generation and nuclear-powered submarines, and its application to drive or power a rocket could one day give NASA a faster, more powerful alternative to chemically driven rockets.
NASA and the Defense Advanced Research Projects Agency are jointly developing NTP technology. They plan to deploy and demonstrate the capabilities of a prototype system in space in 2027 – potentially making it one of the first of its kind to be built and operated by the U.S.
Nuclear thermal propulsion could also one day power maneuverable space platforms that would protect American satellites in and beyond Earth’s orbit. But the technology is still in development.
Conventional chemical propulsion systems use a chemical reaction involving a light propellant, such as hydrogen, and an oxidizer. When mixed together, these two ignite, which results in propellant exiting the nozzle very quickly to propel the rocket.
These systems do not require any sort of ignition system, so they’re reliable. But these rockets must carry oxygen with them into space, which can weigh them down. Unlike chemical propulsion systems, nuclear thermal propulsion systems rely on nuclear fission reactions to heat the propellant that is then expelled from the nozzle to create the driving force or thrust.
In many fission reactions, researchers send a neutron toward a lighter isotope of uranium, uranium-235. The uranium absorbs the neutron, creating uranium-236. The uranium-236 then splits into two fragments – the fission products – and the reaction emits some assorted particles.
More than 400 nuclear power reactors in operation around the world currently use nuclear fission technology. The majority of these nuclear power reactors in operation are light water reactors. These fission reactors use water to slow down the neutrons and to absorb and transfer heat. The water can create steam directly in the core or in a steam generator, which drives a turbine to produce electricity.
Nuclear thermal propulsion systems operate in a similar way, but they use a different nuclear fuel that has more uranium-235. They also operate at a much higher temperature, which makes them extremely powerful and compact. Nuclear thermal propulsion systems have about 10 times more power density than a traditional light water reactor.
Advertisement
Nuclear propulsion could have a leg up on chemical propulsion for a few reasons.
Nuclear propulsion would expel propellant from the engine’s nozzle very quickly, generating high thrust. This high thrust allows the rocket to accelerate faster.
These systems also have a high specific impulse. Specific impulse measures how efficiently the propellant is used to generate thrust. Nuclear thermal propulsion systems have roughly twice the specific impulse of chemical rockets, which means they could cut the travel time by a factor of 2.
Nuclear thermal propulsion history
For decades, the U.S. government has funded the development of nuclear thermal propulsion technology. Between 1955 and 1973, programs at NASA, General Electric and Argonne National Laboratories produced and ground-tested 20 nuclear thermal propulsion engines.
Advertisement
But these pre-1973 designs relied on highly enriched uranium fuel. This fuel is no longer used because of its proliferation dangers, or dangers that have to do with the spread of nuclear material and technology.
High-assay, low- enriched uranium fuel has less material capable of undergoing a fission reaction, compared with highly enriched uranium fuel. So, the rockets needs to have more HALEU fuel loaded on, which makes the engine heavier. To solve this issue, researchers are looking into special materials that would use fuel more efficiently in these reactors.
NASA and the DARPA’s Demonstration Rocket for Agile Cislunar Operations, or DRACO, program intends to use this high-assay, low-enriched uranium fuel in its nuclear thermal propulsion engine. The program plans to launch its rocket in 2027.
Advertisement
As part of the DRACO program, the aerospace company Lockheed Martin has partnered with BWX Technologies to develop the reactor and fuel designs.
The nuclear thermal propulsion engines in development by these groups will need to comply with specific performance and safety standards. They’ll need to have a core that can operate for the duration of the mission and perform the necessary maneuvers for a fast trip to Mars.
Ideally, the engine should be able to produce high specific impulse, while also satisfying the high thrust and low engine mass requirements.
Ongoing research
Before engineers can design an engine that satisfies all these standards, they need to start with models and simulations. These models help researchers, such as those in my group, understand how the engine would handle starting up and shutting down. These are operations that require quick, massive temperature and pressure changes.
Advertisement
The nuclear thermal propulsion engine will differ from all existing fission power systems, so engineers will need to build software tools that work with this new engine.
My group designs and analyzes nuclear thermal propulsion reactors using models. We model these complex reactor systems to see how things such as temperature changes may affect the reactor and the rocket’s safety. But simulating these effects can take a lot of expensive computing power.
Hank Greenberg might be the best baseball player you’ve never heard of.
Greenberg was the first baseman for the Detroit Tigers during the 1930s and 1940s. His career was relatively short – 13 years – and interrupted by two stints of service in World War II.
Yet outside the war years, there were glorious seasons.
Greenberg led the American League in home runs four times, played in five All-Star Games, twice won the American League’s Most Valuable Player Award and, in 1938, nearly broke what was then the game‘s most hallowed record: Babe Ruth’s 60 home runs in one season. In 1956, Greenberg was elected to the Baseball Hall of Fame.
Advertisement
Greenberg was also Jewish, and he is often called America’s first Jewish sports superstar. As Greenberg wrote in his autobiography, that was not an easy honor to bear. Greenberg played during a time of rising antisemitism, and the cruel taunts he suffered from players and fans lasted throughout his career. Vile remarks and bigoted slurs – “kike,” “sheenie” and “Jew bastard” were typical – left a mark on him and the sport he loved.
Along the way, Greenberg also faced a crisis of conscience: his struggle on whether to play during Rosh Hashanah and Yom Kippur, the Jewish High Holidays. He resolved the conflict with a Solomon-like choice, more than 30 years before baseball legend Sandy Koufax pondered the same dilemma during the 1965 World Series.
Greenberg signed a contract with the Tigers in 1930 and played in the minor leagues for the next three years. For many of his teammates, he was the first Jewish person they’d ever met. One told Greenberg, quite seriously, that he thought Jewish people had horns, like the devil.
Once brought up to the major leagues, Greenberg was generally accepted by his teammates. The same could not be said of opposing players and fans, who hounded him throughout his career. The fans insulting Greenberg were in the distinct minority, but they were loud, nonstop and got virtually no resistance from other fans or the media.
Greenberg’s response to the abuse: ignore it. But he reacted at least once, during a game against the Chicago White Sox. One Chicago player tried to injure Greenberg – his autobiography does not report how – and another called him a “yellow Jew son of a bitch.” After the game, Greenberg visited the opposing team’s locker room and demanded to know who the name caller was. At 6 feet, 3 inches tall and 200-plus pounds, Greenberg was intimidating. The room fell silent. The White Sox players never antagonized him again.
In 1934, when he was 23, Greenberg decided he would not play on the Jewish New Year, Rosh Hashanah, a holiday when observant Jews were supposed to pray and not work. But the Tigers were in a close race for the American League pennant. The team needed Greenberg, their star player.
A local newspaper reporter interviewed a Detroit rabbi and asked if it was acceptable for Greenberg to play. The rabbi said it was OK. Deciding at the last minute, Greenberg played and hit two home runs. Detroit won the game, 2-1. The Detroit Free Press ran a headline in Yiddish, with an English translation: “Happy New Year, Hank.”
Advertisement
Ten days later came Yom Kippur, the most sacred of all Jewish holidays. Also known as the Day of Atonement, observant Jews are to spend the day in prayer and self-reflection; baseball was not on the agenda. This time, Greenberg did not play, and attended services instead. When he entered the synagogue, the congregation applauded.
The Tigers lost 5-2 to the New York Yankees that day. But Detroit won the pennant anyway.
“I used to resent being singled out as a Jewish ballplayer, period,” Greenberg said in his autobiography. “I’m not sure why or when it changed, because I’m still not a particularly religious person. Lately, though, I find myself wanting to be remembered not only as a great ballplayer, but even more as a great Jewish ballplayer.”
Meeting Robinson
1947 was Jackie Robinson’s rookie year and Greenberg’s last. Robinson, the first baseman for the Brooklyn Dodgers, had broken the color line and was baseball’s first Black player of the modern era; he was enduring enormous abuse, something Greenberg, now with the Pittsburgh Pirates, clearly understood. They played against each other for the first time at Forbes Field in Pittsburgh in May.
Advertisement
In the fourth inning, Greenberg got to first on a walk, and according to newspaper accounts, he had a few words for Robinson: “I know it’s plenty tough,” he said. “You’re a good ballplayer, and you’ll do all right.”
Greenberg also publicly supported Robinson, one of the few opposing players to do so.
Nearly a half-century later, Supreme Court justices Ruth Bader Ginsburg and Stephen Breyer were considering whether the Supreme Court should meet on Yom Kippur. They too found inspiration from Greenberg; Ginsburg noted that Greenberg did not “betray his conscience.” The Supreme Court did not meet on Yom Kippur that year, and it hasn’t since.
Although not a devout Jew, Greenberg understood that to endure the abuse, he had to embrace his identity. Those athletes of today, recently stung by the vitriol of bigots and trolls, may wish to take heed of the lessons learned by this reticent hero from the previous century, a man whose quiet dignity spoke volumes.
Early screening for neurodevelopmental disorders such as autism is important to ensure childrenhave the support they need to gain the essential skills for daily life. The American Academy of Pediatrics recommends that all children be screened for developmental delays, with additional screening for those who are preterm or have a low birth weight.
However, the U.S. Preventive Services Task Force has called for more research into the effectiveness of current autism screening practices. Primarily based on milestone checklists and symptoms, autism diagnoses also currently rely on observations of behavior that often manifests after crucial developmental stages have passed.
Advertisement
Researchers and clinicians are working to develop simple, reliable tools that could identify early signs or risk factors of a condition before symptoms are obvious. While early screening can lead to the risk of overdiagnosis, understanding a child’s developmental needs can help guide families toward resources that address those needs sooner.
We areresearchers whostudy the role the microbiome plays in a variety of conditions, such as mental illness, autoimmunity, obesity, preterm birth and others. In our recently published research on Swedish children, we found that microbes and the metabolites they produce in the guts of infants – both found in poop and cord blood – could help screen for a child’s risk of neurodevelopmental conditions such as autism. And these differences can be detected as early as birth or within the first year of life. These markers were evident, on average, over a decade before the children were diagnosed.
Microbes as biomarkers
Biomarkers are biological indicators – such as genes, proteins or metabolites in blood, stool or other types of samples – that signal the presence of a condition at a certain point in time. There are no known biomarkers for autism. Efforts to find biomarkers have been largely hindered by the fact that autism has many potential pathways that lead to it, and researchers tend to ignore how these causes may work together as a whole.
One potential biomarker for neurodevelopmental conditions such as autism are gut microbes. The connection between the gut and brain, or the gut-brain axis, is an area of considerable interest among scientists. Gut microbes play significant roles in health, including in immunity, neurotransmitter balance, digestive health and much more.
Gastrointestinal symptoms such as diarrhea, pain and constipation are common in children with autism and ADHD, with as many as 30% to 70% of autism patients also diagnosed with functional gastrointestinal disorders. Untreated GI issues can also lead to additional sleep and behavioral disorders among these children. A small pilot study found that children with autism showed improvements in gastrointestinal and autism-related symptoms after having healthy microbes transferred into their guts, with some benefits lasting up to two years.
Most studies on the microbiome and neurodevelopmental conditions, however, are restricted to people who are already diagnosed with ADHD, autism or other conditions, and these studies often show mixed results. These limitations raise an important question: Does the microbiome play a direct role in the development of autism and other neurodevelopmental conditions, or are changes in microbiome composition a consequence of the conditions themselves?
Some investigations have proposed that the microbiome has little or no association with future autism. However, these studies have a notable limitation: They don’t examine microbial imbalances prior to diagnosis or symptom onset. Instead, these studies focus on children already diagnosed with autism, comparing them to their siblings and unrelated neurotypical children. In most cases, dietary data and samples are collected several years after diagnosis, meaning the study cannot test for whether microbial imbalances cause autism.
Advertisement
Microbes matter
We wondered whether studying the bacteria residing in small children before they are diagnosed or show symptoms of autism or other conditions could give us a clue into their neurodevelopment. So, we examined the cord blood and stool collected at approximately 1 year of age from participants of an ongoing study called All Babies in Southeast Sweden, which follows the health of approximately 17,000 children born between 1997 and 1999 and their parents. We have followed these children since birth, nearly 1,200 of whom were later diagnosed with a neurodevelopmental disorder by age 23.
We found significant differences in bacterial composition and metabolite levels that developed before symptoms of neurodevelopmental conditions – such as gastrointestinal upset, crankiness and sleep problems – as well as formal medical diagnoses. These differences spanned many conditions, including autism, ADHD and speech disorders.
Next, we linked bacteria to neurotransmitters – chemical signals that help brain cells communicate – and vitamins such as riboflavin and vitamin B in the child’s stool. Given previous research on children and adults already diagnosed with a neurodevelopmental disorder, we expected to find differences in the microbiome composition and health between those with and without neurodevelopmental conditions.
But we were surprised to discover just how early these differences emerge. We saw variability in the microbes and metabolites that affect immune and brain health, among others, in the stool collected from the diapers of children around 1 year of age and in umbilical cord blood collected at birth.
Advertisement
The imbalance in microbial composition – what microbiologists call dysbiosis – we observed suggests that incomplete recovery from repeated antibiotic use may greatly affect children during this vulnerable period. Similarly, we saw that repeated ear infections were linked to a twofold increased likelihood of developing autism.
Children who both repeatedly used antibiotics and had microbial imbalances were significantly more likely to develop autism. More specifically, children with an absence of Coprococcus comes, a bacterium linked to mental health and quality of life, and increased prevalence of Citrobacter, a bacterium known for antimicrobial resistance, along with repeated antibiotic use were two to four times more likely to develop a neurodevelopmental disorder.
Antibiotics are necessary for treating certain bacterial infections in children, and we emphasize that our findings do not suggest avoiding their use altogether. Parents should use antibiotics if they are prescribed and deemed necessary by their pediatrician. Rather, our study suggests that repeated antibiotic use during early childhood may signal underlying immune dysfunction or disrupted brain development, which can be influenced by the gut microbiome. In any case, it is important to consider whether children could benefit from treatments to restore their gut microbes after taking antibiotics, an area we are actively studying.
Another microbial imbalance in children who later were diagnosed with neurodevelopmental disorders was a decrease in Akkermansia muciniphila, a bacterium that reinforces the lining of the gut and is linked to neurotransmitters important to neurological health.
Even after we accounted for factors that could influence gut microbe composition, such as how the baby was delivered and breastfeeding, the relationship between imbalanced bacteria and future diagnosis persisted. And these imbalances preceded diagnosis of autism, ADHD or intellectual disability by 13 to 14 years on average, refuting the assumption that gut microbe imbalances arise from diet.
Advertisement
We found that lipids and bile acids were depleted in the cord blood of newborns with future autism. These compounds provide nutrients for beneficial bacteria, help maintain immune balance and influence neurotransmitter systems and signaling pathways in the brain.
Microbiome screening at well-child visits
Microbiome screening is not a common practice in well-child visits. But our findings suggest that detecting imbalances in beneficial and harmful bacteria, especially during critical periods of early childhood development, can provide essential insights for clinicians and families.
There is a long way to go before such screening becomes a standard part of pediatric care. Researchers still need validated methods to analyze and interpret microbiome data in the clinic. It’s also unclear how bacterial differences change across time in children around the world – not just which bacteria are present or absent, but also how they may be shaping immune responses and metabolism. But our findings reaffirm the growing body of evidence that the early gut microbiome plays a key role in shaping neurodevelopment.